CCND1 and breast carcinoma: All novel compounds significantly decreased the concentration of cyclin D1 compared to control value in both tested breast cancer cell lines, but the highest statistically significant decrease was observed after 24 h of incubation with PtPz1 in MCF-7 cells and PtPz5 in MDA-MB-231 cells (Figure 7).